Free Trial

Stock Repurchase Plan Approved by NAMI (NASDAQ:NAMI) Board of Directors

NAMI logo with Business Services background

Key Points

  • The Board of Directors of NAMI (NASDAQ:NAMI) has approved a stock buyback program, allowing the company to repurchase shares through open market purchases.
  • NAMI's stock price recently increased by $0.05, reaching $0.96, with analysts continuing to rate the stock as a "sell", indicating concerns about its value.
  • As of the latest report, NAMI has a 52-week trading range with a low of $0.84 and a high of $7.75, suggesting significant price volatility.
  • Five stocks we like better than NAMI.

NAMI (NASDAQ:NAMI - Get Free Report) declared that its board has approved a stock buyback program on Wednesday, October 22nd, RTT News reports. The company plans to repurchase $0.00 in shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its stock is undervalued.

NAMI Price Performance

NASDAQ NAMI traded up $0.05 on Wednesday, hitting $0.96. The stock had a trading volume of 70,715 shares, compared to its average volume of 37,742. The business's fifty day moving average price is $1.04 and its 200 day moving average price is $1.61. NAMI has a 52-week low of $0.84 and a 52-week high of $7.75.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of NAMI in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, NAMI has a consensus rating of "Sell".

Check Out Our Latest Report on NAMI

About NAMI

Get Free Report)

Jinxin Technology Holding Co engages in the provision of digital content services. The company was founded in August 2015 and is headquartered in Shanghai, China.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NAMI Right Now?

Before you consider NAMI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NAMI wasn't on the list.

While NAMI currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.